Skip to main content
. 2022 Dec 28;15(1):107. doi: 10.3390/pharmaceutics15010107

Figure 11.

Figure 11

Distribution of PBPK modeling application: (a) per disease type; (b) per type of cancer within topic 2, expressed as frequency (%), normalized to 100%.